serological – Page 20 – Communicable Diseases Research

Persistence of Anti-SARS-CoV-2 Antibodies in Long Term Care Residents Over Seven Months After Two COVID-19 Outbreaks

두 번의 COVID-19 발생 후 7개월 동안 장기 요양 시설 입소자의 항 SARS-CoV-2 항체 지속성

Immunology

Published on 2022-01-032022-09-11
Journal: Frontiers in Immunology [Category] MERS, 진단, 치료법,

Serological Biomarkers at Hospital Admission Are Not Related to Long-Term Post-COVID Fatigue and Dyspnea in COVID-19 Survivors

병원 입원 시 혈청학적 바이오마커는 COVID-19 생존자의 장기간의 COVID 이후 피로 및 호흡곤란과 관련이 없습니다

Article

Published on 2022-01-012022-09-11
Journal: Respiration [Category] SARS, 바이오마커,

[키워드] acute phase Alanine Alanine transaminase aspartate Aspartate transaminase association Biomarker Biomarkers Clinical data Coagulopathy cohort study collected collecting data conducted COVID-19 discharge Dyspnea exhibited exhibiting explain fatigue First wave hemoglobin hospital Hospital admission hospital discharge Hospitalization data Infection Lactate lactate dehydrogenase LDH long-COVID lymphocyte Lymphocyte count neutrophil outbreak Patient patients patients hospitalized Platelet Platelet count Platelets platelets count platelets counts Post-COVID post-COVID fatigue Prevalence problem regression analysis serological Spain Standard deviation variance were assessed women
[DOI] 10.1159/000524042 PMC 바로가기 [Article Type] Article

Detection of SARS-CoV-2 in two cats during the second wave of the COVID-19 pandemic in France

프랑스에서 COVID-19 대유행의 두 번째 물결 동안 고양이 두 마리에서 SARS-CoV-2 검출

Article

Published on 2022-01-012022-09-11
Journal: Veterinary medicine and science [Category] SARS, 변종, 치료기술,

SARS-CoV-2 Neutralization in Convalescent Plasma and Commercial Lots of Plasma-Derived Immunoglobulin

회복기 혈장 및 혈장 유래 면역글로불린 상업 로트에서의 SARS-CoV-2 중화

Article

Published on 2022-01-012022-09-12
Journal: BioDrugs : clinical immunotherapeutics, biopharmac [Category] MERS, SARS, 진단,

[키워드] analyzed anti-SARS-CoV-2 anti-SARS-CoV-2 antibody average binding domain Comorbidity Concentration convalescent convalescent plasma Course COVID-19 COVID-19 pandemic D614G determine Donor effective ELISA Final heterogeneous population high variability humoral IgG immunization immunodeficiency Immunoglobulin increase in indicated intravenous investigated lot-to-lot variability maximum microneutralization neutralization neutralization capacity Neutralizing Neutralizing antibody titer neutralizing capacity normalized Patient patient population patients pharmacokinetic PID plasma produced profile Protective question RBD reactivity Research Result SARS-CoV-2 SARS-CoV-2 IgG SARS-COV-2 infection SARS-CoV-2 neutralization serological Standard Support tested the WHO vaccination while
[DOI] 10.1007/s40259-021-00511-9 PMC 바로가기 [Article Type] Article

Low Serological Prevalence of SARS-CoV-2 Antibodies in Cancer Patients at a German University Oncology Center

독일 대학 종양학 센터의 암 환자에서 SARS-CoV-2 항체의 낮은 혈청학적 유병률

Article

Published on 2022-01-012022-09-11
Journal: Oncology research and treatment [Category] MERS, SARS, 진단, 치료기술,

[키워드] active cancer acute respiratory syndrome acute respiratory syndrome coronavirus analyzed Antibody testing Cancer cancer patient Cancer patients cancer type center Chemotherapy coronavirus coronavirus disease Coronavirus disease 2019 Coronavirus disease-19 seroprevalence COVID-19 COVID-19 biobank diagnosed Diagnosis effort Elecsy Elecsys enrolled Epidemiology Europe faster German oncology center Germany hospital Immunity malignancy oncology palliative treatment Pancreatic cancer pandemic Patient patients Patients with cancer Prevalence prevalent preventive measure preventive measures respiratory risk of infection SARS-CoV-2 SARS-CoV-2 antibodies SARS-CoV-2 antibody SARS-COV-2 infection sera serological Severe acute respiratory syndrome coronavirus type 2 single-center Support the patient Treatment university vaccination vaccination rates
[DOI] 10.1159/000520572 PMC 바로가기 [Article Type] Article

COVID-19 Prevalence in UNIVI Group Nursing Homes and Multilevel Geriatric Hospitals: Epidemiological Study of Immunological Status with Rapid Serological Tests for Diagnostic Guidance and Follow Up

Observational Study

Published on 2022-01-012022-10-04
Journal: The journal of nutrition, health & aging [Category] SARS, 임상,

[키워드] activity age Arterial hypertension Atypical being booster Caregivers clinical presentation Contact COVID 19 COVID-19 cutaneous symptoms daily living delirium determine Diabetes Mellitus Diagnosis diagnostics Evolution exceptional Factor favor female Fever France French Geriatric institutions group Health healthcare help home hospital Immunity independent institution Mutation Nurses Nursing PCR test persistence Perspective physician positive positive RT-PCR Prevalence prevalence of COVID-19 professional proportion Protective Rapid rapid serological test Rapid serological tests Reinfection resident risk factor RT-PCR serological serological test Sex status symptomatic syndrome Test vaccination Vaccine
[DOI] 10.1007/s12603-022-1780-1 PMC 바로가기 [Article Type] Observational Study

Low Risk of Serological Cross-Reactivity between the Dengue Virus and SARS-CoV-2-IgG Antibodies Using Advanced Detection Assays

Article

Published on 2022-01-012022-11-15
Journal: Intervirology [Category] SARS, 진단, 치료기술,

COVID-19: Clinical laboratory diagnosis and monitoring of novel coronavirus infected patients using molecular, serological and biochemical markers: A review

COVID-19: 분자, 혈청 및 생화학적 마커를 사용한 신종 코로나바이러스 감염 환자의 임상 실험실 진단 및 모니터링: 검토

Review

Published on 2022-01-012022-09-11
Journal: International journal of immunopathology and pharm [Category] SARS, 바이오마커, 진단, 치료기술,

[키워드] addition Analysis antibody Antibody Response Asymptomatic Asymptomatic cases biochemical biochemical assay biochemical monitoring Characteristics Chemistry clinical clinical chemistry clinical laboratories clinical laboratory Coagulation combating coronavirus disease COVID-19 COVID-19 diagnostics COVID-19 pandemic COVID-19 patients Cytokines Cytokines storm Diagnosis diagnosis and monitoring diagnosis of SARS-CoV-2 diagnostic disease early treatment Epidemiology Federation force Genetic globe Health include infected patient Infection Inflammatory marker inflammatory markers introduced Laboratory laboratory diagnosis laboratory result Laboratory results literature review management Medicine molecular molecular testing NAAT Novel coronavirus novel coronavirus disease nucleic acid nucleic acid amplification Other Pathogenesis Peripheral blood peripheral blood cell peripheral blood cells Platelets provide SARS-CoV-2 SARS-CoV-2 antibody SARS-CoV-2 antibody response SARS-COV-2 infection sequence serological serological test Serological testing Serological tests Support Task Force the disease Treatment utilization variety virus
[DOI] 10.1177/03946320221115316 PMC 바로가기 [Article Type] Review

Anti-CD20 therapies decrease humoral immune response to SARS-CoV-2 in patients with multiple sclerosis or neuromyelitis optica spectrum disorders

항-CD20 요법은 다발성 경화증 또는 시신경척수염 스펙트럼 장애 환자에서 SARS-CoV-2에 대한 체액성 면역 반응을 감소시킵니다.

Clinical Trial

Published on 2022-01-012022-09-12
Journal: Journal of neurology, neurosurgery, and psychiatry [Category] MERS, SARS, 임상, 진단,

Kinetics of SARS-CoV-2-Neutralising Antibodies of Residents of Long-Term Care Facilities

장기요양시설 입소자의 SARS-CoV-2-중화항체 동역학

Article

Published on 2022-01-012022-09-12
Journal: The journal of nutrition, health & aging [Category] SARS, 진단,

[키워드] affected Analysis Antibody titer appear BNT162b2 Care Cellular immune response COVID-19 elderly Epidemic evaluate facility Follow-up high risk Immunity immunosenescence Kinetics material median morbidity Mortality NAb titer NAbs neutralization test neutralizing antibody nine nursing homes outbreak participant Particle Patient patients Pfizer positive serology Quantitative remained resident retroviral S glycoprotein SARS-CoV-2 SARS-COV-2 infection Seroconversion serological Serological assay Serological testing seronegative shown significant difference statistically significant susceptible T cell the SARS-CoV-2 virus timepoint university vaccination Vaccination strategy Vaccine
[DOI] 10.1007/s12603-021-1713-4 PMC 바로가기 [Article Type] Article